NCT02670161
Quality Improvement and Practice Based Research in Neurology Using the EMR
Enrolling by Invitation
PHASE4Ages 18+InterventionalTreatmentEndeavor HealthInvestigator-initiated
~3,300 participants
Updated 2025-08-24 on ClinicalTrials.gov
What's tested:Listed for each disorder below, up to three drugs per disorder (too many characters to list in this field; see Intervention Description)
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
survival free of discontinuation or alternative prevention drug (migraine trial)
Measured over six months
+2 more outcomes measured
Conditions
Where it's being run
1 sites across 1 statesIllinois1
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Diagnosis of brain tumors, epilepsy, migraine, mild cognitive impairment (concussion), mild traumatic brain injury, multiple sclerosis, neuropathy, Parkinson's disease, restless legs syndrome, and stroke.
Eligible to receive any of the three compared treatments according to FDA approval for the indication or off label use according to standard of care.
What this trial measures
- survival free of discontinuation or alternative prevention drug (migraine trial)six months
- survival free of disability measured by FAQ score 9+ (memory trial)one year
- survival free of discontinuation or alternative anti epileptic drug (epilepsy trial)one year